Lethal pulmonary thromboembolism associated with decreased thyroid hormone levels

Abstract

SUMMARYThyroid pathology is rarely involved in the pathogenesis of sudden death in young people. We report here the cases of two young patients with decreased levels of thyroid hormones whose death was caused by an increased thrombotic status, with venous thrombosis and pulmonary thromboembolism. In both cases the thyroid pathology was not considered as the underlying cause of death as the association between this condition and venous thrombosis is still debatable. However its presence may be considered a circumstantial factor, which could increase the severity of the disease and subsequently the lethality rate in pulmonary thromboembolism. An increased awareness for hypothyroidism or subclinical hypothyroidism in clinical practice may lead to a decrease in mortality secondary to thromboembolic disease. Also, increased awareness for thyroid pathology during forensic autopsy in sudden deaths may lead to potentially significant results, that could explain some of the sudden death with an unknown cause, and decrease the number of the so called blank autopsies. Arch Endocrinol Metab. 2015;59(4):355-8

Hypothyroidism increases 90-day postoperative complications in patients undergoing primary single level anterior cervical disectomy and fusion: a matched control analysis

“…Annual trends show the number of ACDF procedures being performed each year are increasing, as is the incidence of hypothyroidism (2,3). This study illustrates hypothyroidism as a modifiable risk factor for decreasing postoperative complications following primary ACDF, and is consistent with the current literature citing the significance of hypothyroidism on postoperative outcomes (10)(11)(12)(13)(14).…”

New Interfaces of Thyroid Hormone Actions With Blood Coagulation and Thrombosis

“…Increased clinical risk of thromboembolism has been incompletely profiled in 2 patient groups with subclinical hypothyroidism. 49,50 This appears to be inconsistent with the body of evidence reviewed above that thyroid hormone positively affects the expression or function of a variety of the components of the coagulation process and is inconsistent with reports of acquired von Willebrand disease in hypothyroidism. 51 However, the principal diagnostic feature of subclinical hypothyroidism is an elevation of circulating pituitary thyrotropin (thyroid-stimulating hormone [TSH]), reflecting the feedback inhibition relationship between circulating thyroid hormone levels and TSH.…”

Association between hyperthyroidism and thromboembolism: A retrospective observational study

“…Furthermore, the risk of developing lethal PE was reported in the case of hypothyroidism, not hyperthyroidism; in 2015, Hostiuc et al . [ 31 ] the reported death of two cases of young patients who have a low level of thyroid hormones and increased thromboembolism status with pulmonary thromboembolism and VT. In the current study, there was no statistically significant difference between diabetes, hypertension, and the use of thyroid dysfunction drugs with the risk of developing VTE events.…”